Forendo Pharma, a Finnish drug developer focusing on new treatments in women’s health, has raised 4 million euros in funding. The investor was Vesalius Biocapital III Partners.
Source: Press Release
Home News and Analysis Firms & Funds Finnish women’s health-focused drug developer Forendo Pharma lands funding
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: